Current Funding Rates on Major CEXs and DEXs Indicate a Return to Market Neutrality
BlockBeats News, July 19 — According to data from Coinglass, the current funding rates on major CEXs and DEXs indicate that the market has returned to a neutral stance. The specific funding rates for major cryptocurrencies are shown in the attached chart.
BlockBeats Note: Funding rates are fees set by cryptocurrency trading platforms to maintain a balance between contract prices and the prices of underlying assets, typically applied to perpetual contracts. This mechanism facilitates the exchange of funds between long and short traders; the trading platform does not collect this fee. It is used to adjust the cost or yield of holding contracts, ensuring that contract prices remain close to the underlying asset prices.
When the funding rate is 0.01%, it represents the benchmark rate. If the funding rate is higher than 0.01%, it indicates a generally bullish market sentiment. If the funding rate is lower than 0.005%, it suggests a generally bearish market sentiment.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Simwon America (SWA.US) applies for Nasdaq IPO, plans to raise up to $50 million
Simwon America, a manufacturer of structural components for electric vehicles, filed for an IPO with the U.S. Securities and Exchange Commission (SEC) last Friday, aiming to raise up to $50 million. The company is a spinoff of Korea’s MS Autotech.
Sui Foundation Invests $30M in DATA Network as It Moves to Sui post-167040 post-167040 post-167040

Equities: Stable oil and yields support stock gains - Danske Bank
Dental caries treatment provider vVardis (VVVV.US) submits US IPO application, expected to raise 200 million USD
vVardis Holding filed for an initial public offering (IPO) with the U.S. Securities and Exchange Commission (SEC) last Friday. The company focuses on self-developed non-invasive restorative therapies for the early treatment of dental caries. The IPO is expected to raise 200 millions USD.
